Table 4. Baseline and selected characteristics of study patients by vital status.

IV tPA: intravenous tissue plasminogen activator; TICI: Thrombolysis in Cerebral Infarction score; MCA: middle cerebral artery.

Table 4. Baseline and selected characteristics of study patients by vital status
Variable	Total            N=178		Living                                  n=123	Deceased                                n=55	P-value
						Gender, n (%)					0.51
Male	97 (54.5)		65 (52.8)	32 (58.2)
Female	81 (45.5)		58 (47.2)	23 (41.8)
Race, n (%)					0.05
White	110 (65.5)		73 (62.9)	37 (71.1)
Black	56 (33.3)		43 (37.1)	13 (25.0)
Asian	2 (1.2)		0 (0.0)	2 (3.9)
Hemicraniectomy, n (%)	4 (2.3)		3 (2.4)	1 (1.8)	1.00
IV tPA, n (%)	76 (48.4)		56 (52.8)	20 (39.2)	0.11
TICI score, n (%)					0.02*
grade 0	17 (9.5)		7 (5.7)	10 (18.2)
grade 1	9 (5.1)		4 (3.3)	5 (9.1)
grade 2a	24 (13.5)		16 (13.0)	24 (14.5)
grade 2b	60 (33.7)		48 (39.0)	60 (21.8)
grade 3	68 (38.2)		48 (39.0)	68 (36.4)
Fraction of MCA territory
infarcted, n (%)					<0.0001*
< 1/3	69 (39.7)		62 (51.6)	7 (13.0)
between 1/3 and 2/3	49 (28.2)		32 (26.7)	17 (31.5)
> 2/3	56 (32.2)		26 (21.7)	30 (55.5)
Stroke side					0.35
Left	92 (54.4)		62 (52.1)	30 (60.0)
Right	77 (45.6)		57 (47.9)	20 (40.0)
Smoking, n (%)	91 (53.2)		65 (54.2)	26 (51.0)	0.70
Atrial fibrillation, n (%)	35 (19.7)		31 (25.2)	4 (7.3)	0.005*
Diabetes mellitus, n (%)	32 (18.0)		22 (17.9)	10 (18.2)	0.96
Hypertension, n (%)	100 (56.2)		74 (60.2)	26 (47.3)	0.11
Hyperlipedemia, n (%)	51 (28.7)		43 (35.0)	8 (14.6)	0.005*
Coronary artery disease, n (%)	20 (11.2)		18 (14.6)	2 (3.6)	0.03*
*p<0.05 statistically significant